Hemostemix Inc (HEM) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.839x

Based on the latest financial reports, Hemostemix Inc (HEM) has a cash flow conversion efficiency ratio of 0.839x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CA$-2.91 Million ≈ $-2.10 Million USD) by net assets (CA$-3.46 Million ≈ $-2.50 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Hemostemix Inc (HEM) net asset quality to measure how much of total assets are equity-financed.

Hemostemix Inc - Cash Flow Conversion Efficiency Trend (2013–2024)

This chart illustrates how Hemostemix Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check HEM cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.

Hemostemix Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Hemostemix Inc ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Check-Cap Ltd. NASDAQ:MBAI	N/A
Magontec Ltd AU:MGL	0.008x
T.Krungthai Industries Public Company Limited BK:TKT	0.037x
Northann Corp. NYSE MKT:NCL	-0.204x
Shanghai Broadband Technology Co Ltd SHG:600608	0.540x
High Arctic Energy Services Inc. TO:HWO	0.005x
Alice QUEEN Ltd AU:AQX	5.144x
Aumake Ltd AU:AUK	0.022x

Annual Cash Flow Conversion Efficiency for Hemostemix Inc (2013–2024)

The table below shows the annual cash flow conversion efficiency of Hemostemix Inc from 2013 to 2024. For the full company profile with market capitalisation and key ratios, see HEM stock market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CA$-7.20 Million ≈ $-5.21 Million	CA$-1.90 Million ≈ $-1.38 Million	0.264x	+29.94%
2023-12-31	CA$-7.37 Million ≈ $-5.33 Million	CA$-1.50 Million ≈ $-1.08 Million	0.203x	-77.46%
2022-12-31	CA$-6.77 Million ≈ $-4.90 Million	CA$-6.10 Million ≈ $-4.41 Million	0.901x	+36.96%
2021-12-31	CA$-5.28 Million ≈ $-3.82 Million	CA$-3.48 Million ≈ $-2.52 Million	0.658x	-87.90%
2020-12-31	CA$-1.10 Million ≈ $-794.78K	CA$-5.98 Million ≈ $-4.32 Million	5.438x	+546.31%
2019-12-31	CA$-4.05 Million ≈ $-2.93 Million	CA$-3.40 Million ≈ $-2.46 Million	0.841x	+115.26%
2018-12-31	CA$487.80K ≈ $352.87K	CA$-2.69 Million ≈ $-1.95 Million	-5.513x	-730.03%
2017-12-31	CA$4.84 Million ≈ $3.50 Million	CA$-3.21 Million ≈ $-2.32 Million	-0.664x	-185.48%
2016-12-31	CA$-3.46 Million ≈ $-2.50 Million	CA$-2.69 Million ≈ $-1.95 Million	0.777x	+103.82%
2015-12-31	CA$174.08K ≈ $125.93K	CA$-3.55 Million ≈ $-2.56 Million	-20.365x	-2102.29%
2014-12-31	CA$3.39 Million ≈ $2.45 Million	CA$-3.13 Million ≈ $-2.27 Million	-0.925x	+52.07%
2013-12-31	CA$573.87K ≈ $415.13K	CA$-1.11 Million ≈ $-800.95K	-1.929x	--

About Hemostemix Inc

V:HEM Canada Biotechnology

Market Cap

$8.18 Million

CA$11.31 Million CAD

Market Cap Rank

#27528 Global

#1172 in Canada

Share Price

CA$0.06

Change (1 day)

+0.00%

52-Week Range

CA$0.05 - CA$0.13

All Time High

CA$13.40